Feng Peng

Prof. Dr. Feng Peng

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2021 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
LWLaicheng Wang
Laicheng Wang
MLMeihua Lin
Meihua Lin
JYJianjian Yu
Jianjian Yu
ZFZongcheng Fan
Zongcheng Fan
SZShunpeng Zhang
Shunpeng Zhang
FPFeng Peng
Feng Peng

23 May 2017 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
HXHong Xie
Hong Xie
GLGaoqing Luo
Gaoqing Luo
YZYong Zheng
Yong Zheng
DHDan Hu
Dan Hu
FPFeng Peng
Feng Peng
LXLiangdi Xie
Liangdi Xie
Background and Objective: Apelin is a bioactive peptide manifesting a potent vasodilatory property. In this meta-analysis, we aimed to investigate for the first time whether circulating apelin differed significantly between hypertensive patients and normotensive controls. Methods: Both PubMed and Embase were searched for eligible articles. Eligibility evaluation and data collection were done independently by two investigators. Weighted mean difference (WMD) with 95% confidence interval (CI) was calculated under random-effects model by STATA. Results: Ten studies were synthesized finally, including 1610 patients and 1105 controls. Overall analysis revealed that circulating apelin was significantly lowered in patients than in controls (WMD = −39.85 pg/mL, 95% CI: −65.56 to −14.15; P = 0.002), with significant heterogeneity (I2 = 89.4%). By race, patients had lower circulating apelin than controls in Caucasian populations (WMD = −79.82 pg/mL, 95% CI: −105.80 to −53.85; P < 0.001), without heterogeneity (I2=0.0%), while no significance was observed in Chinese and African-Americans. Further grouping studies by source of controls found a significant reduction in circulating apelin in studies with hospital-based controls (WMD = −96.28 pg/mL, 95% CI: −129.67 to −62.88; P < 0.001) (I2 = 49.4%), but not in studies with population-based controls. Conclusions: Via a meta-analysis of 10 studies and on 2715 subjects, our findings demonstrated that lowered circulating apelin was significantly associated with an increased risk for hypertension, especially in Caucasian populations.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MZMeijin Zhang
Meijin Zhang
LLLiming Lin
Liming Lin
CXChangsheng Xu
Changsheng Xu
DCDajun Chai
Dajun Chai
FPFeng Peng
Feng Peng
JLJinxiu Lin
Jinxiu Lin
Background and aim. Upregulation of prolyl isomerase‐1 (Pin1) protein expression and activity was associated with the pathogenesis of diabetic vasculopathy through induction of endothelial oxidative stress and inflammation. Moreover, VDR agonist protects against high glucose‐induced endothelial apoptosis through the inhibition of oxidative stress. We aimed to explore the effects of the VDR agonist on diabetes‐associated endothelial dysfunction and the role of Pin1 in this process. Methods. Streptozocin‐induced diabetic mice were randomly treated with vehicle, VDR agonist (10 μg/kg/d, i.g., twice a week), or Pin1 inhibitor, Juglone (1 mg/kg/d, i.p., every other day), for eight weeks. In parallel, human umbilical vein endothelial cells (HUVECs) exposed to high‐glucose condition were treated with 1,25‐dihydroxyvitamin D3 and Juglone or vehicle for 72 hours. Organ chamber experiments were performed to assess endothelium‐dependent relaxation to acetylcholine. Circulatory levels of Pin1, SOD, MDA, IL‐1β, IL‐6, and NO in diabetic mice, Pin1 protein expression and activity, subcellular distribution of p66Shc, and NF‐κB p65 in high glucose‐cultured HUVECs were determined. Results. Both VDR agonist and Juglone significantly improved diabetes‐associated endothelial dysfunction and reduced high glucose‐induced endothelial apoptosis. Mechanistically, the circulatory levels of SOD and NO were increased compared with those of vehicle‐treated diabetic mice. Additionally, Pin1 protein expression and activity, p66Shc mitochondrial translocation, and NF‐κB p65 in high glucose‐cultured HUVECs were also inhibited by VDR agonist and Juglone. Knockdown of VDR abolished the inhibitory effects of VDR agonist on high glucose‐induced upregulation of Pin1 protein expression and activity. Conclusions. VDR agonist prevents diabetic endothelial dysfunction through inhibition of Pin1‐mediated mitochondrial oxidative stress and inflammation.

28 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JXJunxia Xu
Junxia Xu
YHYingqun Huang
Yingqun Huang
HCHongbin Cai
Hongbin Cai
YQYue Qi
Yue Qi
NJNan Jia
Nan Jia
Wenquan NiuWenquan Niu
Wenquan Niu
Currently radiofrequency and cryoballoon ablations are the two standard ablation systems used for catheter ablation of atrial fibrillation; however, there is no universal consensus on which ablation is the optimal choice. We therefore sought to undertake a meta-analysis with special emphases on comparing the efficacy and safety between cryoballoon and radiofrequency ablations by synthesizing published clinical trials. Articles were identified by searching the MEDLINE and EMBASE databases before September 2013, by reviewing the bibliographies of eligible reports, and by consulting with experts in this field. Data were extracted independently and in duplicate. There were respectively 469 and 635 patients referred for cryoballoon and radiofrequency ablations from 14 qualified clinical trials. Overall analyses indicated that cryoballoon ablation significantly reduced fluoroscopic time and total procedure time by a weighted mean of 14.13 (95% confidence interval [95% CI]: 2.82 to 25.45; P = 0.014) minutes and 29.65 (95% CI: 8.54 to 50.77; P = 0.006) minutes compared with radiofrequency ablation, respectively, whereas ablation time in cryoballoon ablation was nonsignificantly elongated by a weighted mean of 11.66 (95% CI: −10.71 to 34.04; P = 0.307) minutes. Patients referred for cryoballoon ablation had a high yet nonsignificant success rate of catheter ablation compared with cryoballoon ablation (odds ratio; 95% CI; P: 1.34; 0.53 to 3.36; 0.538), and cryoballoon ablation was also found to be associated with the relatively low risk of having recurrent atrial fibrillation (0.75; 0.3 to 1.88; 0.538) and major complications (0.46; 0.11 to 1.83; 0.269). There was strong evidence of heterogeneity and low probability of publication bias. Our findings demonstrate greater improvement in fluoroscopic time and total procedure duration for atrial fibrillation patients referred for cryoballoon ablation than those for radiofrequency ablation.

24 July 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YWYuansheng Wu
Yuansheng Wu
MZMeijin Zhang
Meijin Zhang
CXChangsheng Xu
Changsheng Xu
DCDajun Chai
Dajun Chai
FPFeng Peng
Feng Peng
JLJinxiu Lin
Jinxiu Lin
Background and purpose. Vascular smooth muscle cells (VSMC) proliferation and migration is the important pathological process of diabetic atherosclerosis. Bromine domain protein 4 (BRD4) is involved in cell proliferation and inflammatory disease. Pin1 enhances BRD4 stability and its transcriptional activity. This study aimed to explore the possible mechanism of Pin1/BRD4 in diabetic atherosclerosis. Methods. Diabetic Apoe-/- mice induced by streptozotocin were treated with vehicle, the Pin1 inhibitor juglone, or the BRD4 inhibitor JQ1 for 3 weeks. VSMCs were pretreated with juglone, JQ1, or vehicle for 45 min, and then exposed to high glucose for 48 h. Hematoxylin–eosin staining was performed to assess atherosclerotic plaques of the thoracic aorta. Western blotting was used to detect expression levels of Pin1, BRD4, cyclin D1, and matrix metalloproteinase-9 (MMP-9) in the thoracic aorta and VSMCs. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and transwell assay were used to measure proliferation and migration of VSMCs. Results. Juglone and JQ1 significantly improved atherosclerosis of diabetic Apoe-/- mice and reduced high glucose-induced VSMC proliferation and migration. Cyclin D1 and MMP-9 levels in the thoracic aorta were lower in diabetic Apoe-/- mice treated with juglone and JQ1 compared with vehicle-treated diabetic Apoe-/- mice. Additionally, BRD4 protein expression in high glucose-induced VSMCs was inhibited by juglone and JQ1. Upregulation of Pin1 expression by transduction of the Pin1 plasmid vector promoted BRD4 expression induced by high glucose, and stimulated proliferation and migration of VSMCs. Conclusions. Inhibition of Pin1/BRD4 pathway may improve diabetic atherosclerosis by inhibiting proliferation and migration of VSMCs.

23 April 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
JYJianjian Yu
Jianjian Yu
DHDan Hu
Dan Hu
LWLaicheng Wang
Laicheng Wang
ZFZongcheng Fan
Zongcheng Fan
CXChangsheng Xu
Changsheng Xu
FPFeng Peng
Feng Peng
Diabetes is a potential risk factor for gastric cancer (GC). Pin1, a peptidyl–prolyl cis/trans isomerase, promotes GC cell proliferation and migration. The role and underlying mechanism of the Pin1/BRD4 axis in hyperglycemia-induced proliferation and migration of GC cells were analyzed in vivo and in vitro. Proliferation and migration of GC cells were measured; Pin1 and BRD4 expression of the cell cycle were determined. Pin1 and BRD4 were downregulated by transfecting Pin1 shRNA lentivirus into GC cells and JQ1-intervention GC cells. Tumor formation and lung metastasis were assessed in vivo. Inhibition of Pin1 and BRD4 significantly suppressed high-glucose (HG)-induced GC cell proliferation and migration. HG enhanced G1/S cell-cycle transition, associated with increased Pin1 and BRD4 expression. Silencing Pin1 significantly downregulated the expression of BRD4 and NAP1L1 and upregulated that of P21 in GC cells. In vivo studies indicated that hyperglycemia promotes tumor growth and lung metastasis by inducing Pin1 and BRD4 expression. Thus, Pin1/BRD4 plays an important role in hyperglycemia-promoted tumor growth. The significance of these findings toward improved prognosis of diabetic patients with GC cannot be underestimated.